Skip to main content

Allosteric Modulation of G Protein-Coupled Receptors

  • 1st Edition - February 5, 2022
  • Latest edition
  • Editor: Robert Laprairie
  • Language: English

Allosteric Modulation of G Protein-Coupled Receptors reviews fundamental information on G protein-coupled receptors (GPCRs) and allosteric modulation, presenting original research… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Description

Allosteric Modulation of G Protein-Coupled Receptors reviews fundamental information on G protein-coupled receptors (GPCRs) and allosteric modulation, presenting original research in the area and collectively providing a comprehensive description of key issues in GPCR allosteric modulation. The book provides background on core concepts of molecular pharmacology while also introducing the most important advances and studies in the area. It also discusses key methodologies. This is an essential book for researchers and advanced students engaged in pharmacology, toxicology and pharmaceutical sciences training and research.

Many of the GPCR-targeted drugs released in the past decade have specifically worked via allosteric mechanisms. Unlike direct orthosteric-acting compounds that occupy a similar receptor site to that of endogenous ligands, allosteric modulators alter GPCR-dependent signaling at a site apart from the endogenous ligand. Recent methodological and analytical advances have greatly improved our ability to understand the signaling mechanisms of GPCRs. We now know that allostery is a common regulatory mechanism for all GPCRs and not – as we once believed – unique to a few receptor subfamilies.

Key features

  • Introduces background on core concepts of molecular pharmacology, including statistical analyses, non-linear regression, complex models and GPCR-dependent signal transduction as they relate to allosteric modulation
  • Discusses critical advances and landmark studies, including discoveries in the area of GPCR allosteric modulation, which are reviewed for their importance in positive and negative regulation, protein-protein interactions, and small molecule drug discovery
  • Includes key methodologies used to study allosteric modulation at the in silico, in vitro, and in vivo levels of drug discovery and characterization

Readership

Researchers, graduate, and post-graduate students engaged in pharmacology, toxicology, neuropharmacology and pharmaceutical sciences training and research.
Advanced undergraduate students

Table of contents

Part I: Core Concepts

1. G Protein-Coupled Receptor-Dependent Signal Transduction: Orthosteric and Allosteric Mechanisms

2. Analysis of Allosteric Modulation: Curve-Fitting and Modelling

3. Critical Caveats: Probe-Dependence and Ligand Bias

4. Ions as Allosteric Modulators

5. Small Molecules as Allosteric Modulators

6. Oligomerization: Protein-Protein Allosteric Effects

Part II: Critical Advances

7. Crystal Structures of G Protein-Coupled Receptors in Complex with Allosteric Modulators

8. Receptor Subtype Selectivity: Muscarinic Receptors

9. Receptor Subtype Selectivity: Opioid Receptors

10. Lipid-based Allosteric Modulators

11. Moving from Cells to Animals: Challenges of Studying Allosteric Modulators In vivo

12. Disease Targets: Pain

13. Disease Targets: Anxiety

14. New Drug Targets: Clinical Translation of Allosteric Modulators, Cinacalcet

Part III: Key Methodologies

15. In silico Analysis of Allosteric Modulators

16. Mapping Structure-Activity Relationships for Allosteric Modulators

17. Kinetic Considerations of Allosteric Modulators

18. Binding and Ligand Affinity

19. Photoaffinity Ligands and the Metabotropic Glutamate Receptors

20. Biosensors for the Study of Allosteric Modulation

Product details

  • Edition: 1
  • Latest edition
  • Published: February 5, 2022
  • Language: English

About the editor

RL

Robert Laprairie

Robert Laprairie is the GlaxoSmithKline-Canadian Institutes of Health Research chair in Drug Discovery and Development in the College of Pharmacy and Nutrition at the University of Saskatchewan. He currently serves as the President and Director of Education and Trainee Initiatives for the Canadian Consortium for the Investigation of Cannabinoids (CCIC). His teaching responsibilities include basic molecular pharmacology and neuroscience in the undergraduate and graduate Pharmacy programs. He is also involved in committee work with the Canadian Institutes of Health Research and the Animal Research Ethics Board of the University of Saskatchewan. Dr. Laprairie has published more than 50 articles on pharmacology with a focus on the endocannabinoid system and allosteric modulators.
Affiliations and expertise
Assistant Professor and CIHR-GlaxoSmithKline Chair in Drug Discovery and Development, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada

View book on ScienceDirect

Read Allosteric Modulation of G Protein-Coupled Receptors on ScienceDirect